Autoimmune GFAP-A is a relatively new autoimmune disease of the central nervous system that was first named by Fang et al. (18) from the Mayo Clinic, USA, in 2016; the authors reported that an IgG that specifically targeted GFAP was present in experimental animals and patients with this disease. The gene discussed is GFAP; the disease is autoimmune disorder of central nervous system.